Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.670
-0.001 (-0.16%)
At close: Oct 29, 2024, 4:00 PM
0.673
+0.003 (0.52%)
After-hours: Oct 29, 2024, 4:55 PM EDT

Bolt Biotherapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for BOLT stock have an average target of 1.25, with a low estimate of 1.00 and a high estimate of 1.50. The average target predicts an increase of 86.60% from the current stock price of 0.67.

Analyst Consensus: Hold
Target Low Average Median High
Price $1.00 $1.25 $1.50 $1.50
Change +49.28% +86.60% +123.91% +123.91%
* Price targets were last updated on May 15, 2024.

Analyst Ratings

The average analyst rating for BOLT stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 000000
Buy 000000
Hold 555555
Sell 000000
Strong Sell 000000
Total 555555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Aug 15, 2024
Leerink Partners
Leerink Partners
Hold
Downgrades
$3$1
Hold Downgrades $3$1 +49.28% May 15, 2024
Jones Trading
Jones Trading
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 15, 2024
Stifel
Stifel
Hold
Downgrades
$6$1.5
Hold Downgrades $6$1.5 +123.91% May 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
9.16M
from 7.88M
Increased by 16.30%
Revenue Next Year
3.72M
from 9.16M
Decreased by -59.44%
EPS This Year
-1.55
from -1.83
EPS Next Year
-1.31
from -1.55
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
215.00K231.00K1.26M5.73M7.88M9.16M3.72M5.75M
Revenue Growth
-7.44%445.45%354.68%37.48%16.30%-59.44%54.70%
EPS
-15.29-28.89-2.97-2.36-1.83-1.55-1.31-1.13
EPS Growth
--------
Forward PE
--------
No. Analysts -----777
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 11.0M 10.5M 12.8M
Avg 9.2M 3.7M 5.7M
Low 7.3M n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
40.0%
14.5%
243.4%
Avg
16.3%
-59.4%
54.7%
Low
-7.9%
- -

EPS Forecast

EPS 20242025202620272028
High -1.41 -0.96 -0.49
Avg -1.55 -1.31 -1.13
Low -1.63 -2.11 -2.20

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.